PINK COPYRIGHT: A GROWING DANGER?

A new trend is emerging within the drug scene: "Pink copyright," formally known as Flunitramadol. This synthetic opioid is being marketed as a crystal , often presented as copyright, posing a significant threat to people. Its seemingly low price and simple accessibility are leading its swift rise